H.R. 1035 · 116th Congress

Prescription Drug Price Transparency Act

Stage
In committee
Sponsor
Doug Collins
Introduced
2019-02-07
Latest action
2019-02-07 · Introduced in House

Action history

  1. 2019-02-07Introduced in House
  2. 2019-02-07Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  3. 2019-02-07Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. 2019-02-07Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. 2019-02-07Referred to the Subcommittee on Health.